Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Pramod Srivastava

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Physiology

Antigen Presentation

Disorders

Anatomy

Concepts & Ideas

Molecular Sequence Data

Procedures

Immunization

Phenomena

Protein Binding

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
10
Binder, Robert
10
Blachere, Nathalie
7
Basu, Sreyashi
7
Ménoret, Antoine
4
Maki, Robert
4
Heike, Michael
3
Levey, Daniel
3
Callahan, Margaret
3
Chandawarkar, Rajiv
3
Udono, H
2
Brander, Christian
2
Li, Zihai
2
Janetzki, Sylvia
1
Klimstra, David
1
Anderson, Sylvia

Sign-in to see all Coauthors

Publications

TOP 3
Srivastava Pramod K; Callahan Margaret K; Mauri Matteo M
Treating human cancers with heat shock protein-peptide complexes: the road ahead.
Buckwalter Matthew R; Srivastava Pramod K
"It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.
Srivastava Pramod K
New jobs for ancient chaperones.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pramod Srivastava (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Srivastava Pramod K; Callahan Margaret K; Mauri Matteo M
Treating human cancers with heat shock protein-peptide complexes: the road ahead.
Expert opinion on biological therapy 2009;9(2):179-86.
2008: Buckwalter Matthew R; Srivastava Pramod K
"It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.
Seminars in immunology 2008;20(5):296-300.
2008: Srivastava Pramod K
New jobs for ancient chaperones.
Scientific American 2008;299(1):50-5.
2008: Callahan Margaret K; Garg Manish; Srivastava Pramod K
Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(5):1662-7.
2007: Maki Robert G; Livingston Philip O; Lewis Jonathan J; Janetzki Sylvia; Klimstra David; Desantis Diann; Srivastava Pramod K; Brennan Murray F
A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.
Digestive diseases and sciences 2007;52(8):1964-72.
2006: Callahan Margaret K; Wohlfert Elizabeth A; Ménoret Antoine; Srivastava Pramod K
Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(12):8393-9.
2006: Srivastava Pramod K
Therapeutic cancer vaccines.
Current opinion in immunology 2006;18(2):201-5.
2005: Levey Daniel L; Brander Christian; Srivastava Pramod K
The potential of heat shock protein-peptide complexes as a therapeutic HIV vaccine.
Journal of HIV therapy 2005;10(3):56-9.
2005: Li Zihai; Qiao Yi; Liu Bei; Laska Elizabeth J; Chakravarthi Priyamvadha; Kulko Judith M; Bona Robert D; Fang Min; Hegde Upendra; Moyo Victor; Tannenbaum Susan H; Ménoret Antoine; Gaffney Judy; Glynn Laura; Runowicz Carolyn D; Srivastava Pramod K
Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4460-8.
2005: Binder Robert J; Srivastava Pramod K
Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells.
Nature immunology 2005;6(6):593-9.
2005: Srivastava Pramod K
Immunotherapy for human cancer using heat shock protein-peptide complexes.
Current oncology reports 2005;7(2):104-8.
2004: SenGupta Devi; Norris Philip J; Suscovich Todd J; Hassan-Zahraee Mina; Moffett Howell F; Trocha Alicja; Draenert Rika; Goulder Philip J R; Binder Robert J; Levey Daniel L; Walker Bruce D; Srivastava Pramod K; Brander Christian
Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1987-93.
2004: Binder Robert J; Srivastava Pramod K
Essential role of CD91 in re-presentation of gp96-chaperoned peptides.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(16):6128-33.
2003: Basu Sreyashi; Srivastava Pramod K
Fever-like temperature induces maturation of dendritic cells through induction of hsp90.
International immunology 2003;15(9):1053-61.
2003: Srivastava Pramod K
Hypothesis: controlled necrosis as a tool for immunotherapy of human cancer.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():4.
2002: Binder Robert J; Kumar Sumeet K; Srivastava Pramod K
Naturally formed or artificially reconstituted non-covalent alpha2-macroglobulin-peptide complexes elicit CD91-dependent cellular immunity.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():16.
2002: Makki Amira; Weidt Gunnar; Blachere Nathalie E; Lefrançois Leo; Srivastava Pramod K
Immunization against a dominant tumor antigen abrogates immunogenicity of the tumor.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():4.
2001: Ménoret A; Li Z; Niswonger M L; Altmeyer A; Srivastava P K
An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility of class I is an aminopeptidase.
The Journal of biological chemistry 2001;276(36):33313-8.
2001: Binder R J; Blachere N E; Srivastava P K
Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.
The Journal of biological chemistry 2001;276(20):17163-71.
2001: Binder R J; Karimeddini D; Srivastava P K
Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):4968-72.
2001: Levey D L; Udono H; Heike M; Srivastava P K
Identification of a tumor-associated contact-dependent activity which reversibly downregulates cytolytic function of CD8+ T cells.
Cancer immunity : a journal of the Academy of Cancer Immunology 2001;1():5.
2001: Basu S; Binder R J; Ramalingam T; Srivastava P K
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
Immunity 2001;14(3):303-13.
2001: Matsutake T; Srivastava P K
The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):3992-7.
2001: Srivastava P K; Jaikaria N S
Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.
Methods in molecular biology (Clifton, N.J.) 2001;156():175-86.
2000: Binder R J; Anderson K M; Basu S; Srivastava P K
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6029-35.
2000: Ménoret A; Chandawarkar R Y; Srivastava P K
Natural autoantibodies against heat-shock proteins hsp70 and gp96: implications for immunotherapy using heat-shock proteins.
Immunology 2000;101(3):364-70.
2000: Srivastava P K
Immunotherapy of human cancer: lessons from mice.
Nature immunology 2000;1(5):363-6.
2000: Basu S; Binder R J; Suto R; Anderson K M; Srivastava P K
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.
International immunology 2000;12(11):1539-46.
2000: Binder R J; Harris M L; Ménoret A; Srivastava P K
Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(5):2582-7.
2000: Binder R J; Han D K; Srivastava P K
CD91: a receptor for heat shock protein gp96.
Nature immunology 2000;1(2):151-5.
1999: Ménoret A; Peng P; Srivastava P K
Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
Biochemical and biophysical research communications 1999;262(3):813-8.
1999: Chandawarkar R Y; Wagh M S; Srivastava P K
The dual nature of specific immunological activity of tumor-derived gp96 preparations.
The Journal of experimental medicine 1999;189(9):1437-42.
1999: Basu S; Srivastava P K
Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity.
The Journal of experimental medicine 1999;189(5):797-802.
1999: Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava P K; Nakayama E
Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(3):1303-9.
1998: Janetzki S; Blachere N E; Srivastava P K
Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(4):269-76.
1998: Srivastava P K; Menoret A; Basu S; Binder R J; McQuade K L
Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.
Immunity 1998;8(6):657-65.
1997: Blachere N E; Li Z; Chandawarkar R Y; Suto R; Jaikaria N S; Basu S; Udono H; Srivastava P K
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
The Journal of experimental medicine 1997;186(8):1315-22.
1997: Tamura Y; Peng P; Liu K; Daou M; Srivastava P K
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.
Science (New York, N.Y.) 1997;278(5335):117-20.
1997: Peng P; Ménoret A; Srivastava P K
Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography.
Journal of immunological methods 1997;204(1):13-21.
1996: Srivastava P K
Do human cancers express shared protective antigens? or the necessity of remembrance of things past.
Seminars in immunology 1996;8(5):295-302.
1995: Blachere N E; Srivastava P K
Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors.
Seminars in cancer biology 1995;6(6):349-55.
1995: Levey D L; Srivastava P K
T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
The Journal of experimental medicine 1995;182(4):1029-36.
1994: Srivastava P K; Udono H
Heat shock protein-peptide complexes in cancer immunotherapy.
Current opinion in immunology 1994;6(5):728-32.
1994: Anderson S L; Shen T; Lou J; Xing L; Blachere N E; Srivastava P K; Rubin B Y
The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells.
The Journal of experimental medicine 1994;180(4):1565-9.
1994: Udono H; Srivastava P K
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(11):5398-403.
1994: Heike M; Blachere N E; Srivastava P K
Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice.
Immunobiology 1994;190(4-5):411-23.
1994: Heike M; Blachere N E; Wölfel T; Meyer zum Büschenfelde K H; Störkel S; Srivastava P K
Membranes activate tumor- and virus-specific precursor cytotoxic T lymphocytes in vivo and stimulate tumor-specific T lymphocytes in vitro: implications for vaccination.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(3):165-74.
1994: Udono H; Levey D L; Srivastava P K
Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):3077-81.
1994: Srivastava P K; Udono H; Blachere N E; Li Z
Heat shock proteins transfer peptides during antigen processing and CTL priming.
Immunogenetics 1994;39(2):93-8.
1993: Blachere N E; Udono H; Janetzki S; Li Z; Heike M; Srivastava P K
Heat shock protein vaccines against cancer.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(4):352-6.
1993: Udono H; Srivastava P K
Heat shock protein 70-associated peptides elicit specific cancer immunity.
The Journal of experimental medicine 1993;178(4):1391-6.
1993: Maki R G; Eddy R L; Byers M; Shows T B; Srivastava P K
Mapping of the genes for human endoplasmic reticular heat shock protein gp96/grp94.
Somatic cell and molecular genetics 1993;19(1):73-81.
1991: Srivastava P K; Heike M
Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation?
Seminars in immunology 1991;3(1):57-64.
1991: Srivastava P K; Maki R G
Stress-induced proteins in immune response to cancer.
Current topics in microbiology and immunology 1991;167():109-23.
1990: Maki R G; Old L J; Srivastava P K
Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5658-62.

Sign-in to see more